Home Science Team Press Contact

The Team

The team behind
HelioFlux.

Dr. Nirosha Murugan

Canada Research Chair · Tissue Biophysics

40+ peer-reviewed publications
Harvard Wyss Fellow · Allen Discovery Center Postdoctoral Researcher

Dr. Nirosha Murugan
Interim CEO, Chief Scientist & Co-Founder

Awards & Recognition

  • Optica Foundation Challenge Grant · 2023
  • Faculty of Science Tier 2 Distinguished Research Chair · 2023
  • Tier 2 Canada Research Chair, Tissue Biophysics · 2022
  • Minister of Colleges and Universities Award of Excellence · 2022
  • STRIVE Young Professional Visionary Award · 2022
  • NSERC Science Exposed Jury Prize Winner · 2021
Canada Research Chair Wilfrid Laurier University Tufts Postdoc (Levin Lab) Harvard Wyss Fellow

Dr. Nirosha J. Murugan is Canada Research Chair in Tissue Biophysics at Wilfrid Laurier University and the scientific co-founder of HelioFlux. Her lab has secured $1.6M in non-dilutive grants and produced 40+ peer-reviewed publications across cancer biology, regenerative medicine, neuroscience, and quantum biology.

She earned her Ph.D. in Biomolecular Sciences at Laurentian University, where she pioneered the quantum-sensor-based cancer detection technology now commercialized through HelioFlux. As a postdoctoral researcher in Dr. Michael Levin's lab at the Allen Discovery Center at Tufts University, she advanced ion-channel bioelectricity as a mechanism of tissue patterning and co-developed a drug delivery system to induce limb regeneration in non-regenerative species.

A dedicated mentor, Dr. Murugan is deeply committed to making biophysics accessible to the next generation of health innovators.

The Team

Leadership

Kelly Lucas
Kelly Lucas
President & Co-Founder
Kelly co-founded HelioFlux to bring Nirosha's biophotonic research out of the lab and into clinical practice. She leads fundraising, strategy, and commercial partnerships — growing the company from a research concept to a funded startup with a patent-pending platform and a first human study on the horizon. Before HelioFlux, Kelly studied biology at UNC Chapel Hill and earned an MBA from Indiana University's Kelley School of Business. She's driven by one belief: nobody should die from a cancer caught too late.
Jim Armstrong
Jim Armstrong
CFO
Multiple Forbes Midas List honoree. Pre-launch investor in PayPal, NetZero, and CarsDirect. Founding Partner of March Capital Partners, Managing Director of Clearstone Venture Partners and Composite Ventures. Oversees HelioFlux's financial strategy and capital allocation, milestone execution, and investor relationships.
Glenn Lucas
Glenn Lucas
Chief Strategy Officer
President of Lucas Telepictures, CSO at Escape AI Media. Executive Produced Extract (Miramax, dir. Mike Judge) as Head of Business Development at Ternion Pictures. Strategic Advisor at Composite Ventures. Leads commercial strategy and media partnerships at HelioFlux.

Advisory

Scientific Advisory Board

Dr. Michael Levin
Dr. Michael Levin
Scientific Advisor
Vannevar Bush Distinguished Professor at Tufts University. Director of the Allen Discovery Center and the Tufts Center for Regenerative and Developmental Biology. Pioneer in bioelectric control of cell behavior. Dr. Murugan's postdoctoral mentor and the scientific foundation HelioFlux is built on.
Dr. David Kaplan
Dr. David Kaplan
Scientific Advisor
Stern Family Endowed Professor of Biomedical Engineering at Tufts University. Director of the Tufts Center for Cellular Agriculture. AIMBE Fellow. Collaborated directly with Dr. Murugan on bioengineered tissue systems during her Tufts postdoctoral work.
Dr. Nicolas Rouleau
Dr. Nicolas Rouleau
Scientific Advisor
Assistant Professor of Health Sciences at Wilfrid Laurier University. Adjunct Professor of Biomedical Engineering at Tufts. His Rouleau Lab develops 3D models of Alzheimer's and neurological disorders. Collaborates with Dr. Levin on cognitive systems research underlying HelioFlux's brain monitoring work.

Get in touch

We're raising our next round and looking for mission-driven partners.

Request Deck
© 2026 HelioFlux Inc.Not FDA cleared. Not intended to diagnose or treat any disease.